STADA Arzneimittel selected Lease Administration by Nakisa to address IFRS 16 compliance. The customer was looking for an end-to-end lease accounting solution that could support compliance with the new lease accounting standard. In addition, STADA Arzneimittel required a solution that could natively integrate with their existing SAP ERP.
Lease Administration by Nakisa’s ability to automate finance and accounting through push and pull ERP integration made it an excellent fit for STADA Arzneimittel. Lease Administration by Nakisa’s powerful technology allows world leading companies to adopt the software quickly and configure as necessary.
About STADA Arzneimittel
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH.
A global leader in enterprise business solutions for Organization Transformation and Accounting and Compliance, Nakisa delivers innovative, forward-thinking and robust human resource and financial management solutions that advance your business strategies.
Working with a global network of partners and as one of the few Solution Extension (SolEx) partners of SAP® since 2007, Nakisa serves 800+ enterprise customers and over 4 million subscribers in 24 industries. Nakisa is proud to work with some of the world’s most renowned brands.